UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pilocarpine HCl 1.25% for treatment of presbyopia after laser vision correction: pooled analysis of two phase 3 randomized trials (GEMINI 1 and 2)

Journal of cataract and refractive surgery, 2024-01, Vol.50 (1), p.57-63

2024

Volltextzugriff (PDF)

Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study

Ophthalmology (Rochester, Minn.), 2014-02, Vol.121 (2), p.475-483

2014

Volltextzugriff (PDF)

Omidenepag Isopropyl in Latanoprost Low/Nonresponders With Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 3, Nonrandomized, Two-Phase, Open-Label Study

Journal of glaucoma, 2023-12, Vol.32 (12), p.999-1005

2023

Volltextzugriff (PDF)

Phase 3 Randomized Study of Efficacy and Safety of a Dexamethasone Intracanalicular Insert in Patients With Allergic Conjunctivitis

American journal of ophthalmology, 2021-09, Vol.229, p.288-300

2021

Volltextzugriff (PDF)

A Randomized, Multicenter Phase 3 Clinical Trial Evaluating Intracanalicular Dexamethasone Insert for the Treatment of Allergic Conjunctivitis

Clinical ophthalmology (Auckland, N.Z.), 2024-01, Vol.18, p.2671-2684

2024

Volltextzugriff (PDF)

Efficacy and Safety of the Melanocortin Pan-Agonist PL9643 in a Phase 2 Study of Patients with Dry Eye Disease

Journal of ocular pharmacology and therapeutics, 2023-11, Vol.39 (9), p.600-610

2023

Volltextzugriff (PDF)

A randomized, vehicle-controlled, Phase 2b study of two concentrations of the TRPM8 receptor agonist AR-15512 in the treatment of dry eye disease (COMET-1)

The ocular surface, 2022-10, Vol.26, p.166-173

2022

Volltextzugriff (PDF)

A Phase 2 Randomized, Double-Masked, Placebo-Controlled Study of a Novel Integrin Antagonist (SAR 1118) for the Treatment of Dry Eye

American journal of ophthalmology, 2012-06, Vol.153 (6), p.1050-1060.e1

2012

Volltextzugriff (PDF)

Plasma Pharmacokinetic Parameters of Dexamethasone Following Administration of a Dexamethasone Intracanalicular Insert in Healthy Adults

Clinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.15, p.2055-2061

2021

Volltextzugriff (PDF)

Ocular Itch Relief with Alcaftadine 0.25% Versus Olopatadine 0.2% in Allergic Conjunctivitis: Pooled Analysis of Two Multicenter Randomized Clinical Trials

Advances in therapy, 2014-10, Vol.31 (10), p.1059-1071

2014

Volltextzugriff (PDF)

Alcaftadine 0.25% Versus Olopatadine 0.2% In Prevention Of Ocular Itching In Allergic Conjunctivitis

Journal of allergy and clinical immunology, 2014-02, Vol.133 (2), p.AB278-AB278

2014

Volltextzugriff (PDF)

Effect of alcaftadine 0.25% on ocular itch associated with seasonal or perennial allergic conjunctivitis: a pooled analysis of two multicenter randomized clinical trials

Clinical ophthalmology (Auckland, N.Z.), 2015-01, Vol.9 (default), p.765-772

2015

Volltextzugriff (PDF)

Lifitegrast Ophthalmic Solution 5.0% for Treatment of Dry Eye Disease

Ophthalmology (Rochester, Minn.), 2014-02, Vol.121 (2), p.475-483

2014

Volltextzugriff (PDF)

Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2)

American journal of ophthalmology, 2018-02, Vol.186, p.116-127

2018

Volltextzugriff (PDF)

Phase 3 Randomized Double-Masked Study of Efficacy and Safety of Once-Daily 0.77% Olopatadine Hydrochloride Ophthalmic Solution in Subjects With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge Model

Cornea, 2015-10, Vol.34 (10), p.1245-1251

2015

Volltextzugriff (PDF)

Topical Anti-TNFα Agent Licaminlimab (OCS-02) Relieves Persistent Ocular Discomfort in Severe Dry Eye Disease: A Randomized Phase II Study

Clinical ophthalmology (Auckland, N.Z.), 2022-01, Vol.16, p.2167-2177

2022

Volltextzugriff (PDF)

Topical Anti-TNF[alpha] Agent Licaminlimab Relieves Persistent Ocular Discomfort in Severe Dry Eye Disease: A Randomized Phase II Study

Clinical ophthalmology (Auckland, N.Z.), 2022-07, Vol.16, p.2167

2022

Volltextzugriff (PDF)

Topical Anti-TNF[alpha] Agent Licaminlimab

Clinical ophthalmology (Auckland, N.Z.), 2022-07, Vol.16, p.2167

2022

Volltextzugriff (PDF)

Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Three-Month Data from a Randomized Phase 3 Trial

American journal of ophthalmology, 2019-11, Vol.207, p.248-257

2019

Volltextzugriff (PDF)

A Water-free 0.1% Cyclosporine A Solution for Treatment of Dry Eye Disease: Results of the Randomized Phase 2B/3 ESSENCE Study

Cornea, 2021-10, Vol.40 (10), p.1290-1297

2021

Volltextzugriff (PDF)

Brimonidine Ophthalmic Solution 0.025% for Reduction of Ocular Redness: A Randomized Clinical Trial

Optometry and vision science, 2018-03, Vol.95 (3), p.264-271

2018

Volltextzugriff (PDF)

Repository Corticotropin Injection (Acthar® Gel) for Refractory Severe Noninfectious Keratitis: Efficacy and Safety from a Phase 4, Multicenter, Open-Label Study

Ophthalmology and therapy, 2021-12, Vol.10 (4), p.1077-1092

2021

Volltextzugriff (PDF)

Low-dose brimonidine for relief of ocular redness: integrated analysis of four clinical trials

Clinical and experimental optometry, 2019-03, Vol.102 (2), p.131-139

2019

Volltextzugriff (PDF)

Vehicle-Controlled, Phase 2 Clinical Trial of a Sustained-Release Dexamethasone Intracanalicular Insert in a Chronic Allergen Challenge Model

Journal of ocular pharmacology and therapeutics, 2017-03, Vol.33 (2), p.79-90

2017

Volltextzugriff (PDF)

Efficacy and Safety of Topical Cyclosporine in Dry Eye Subjects Who Engage in Electronic Visual Tasking—The EMPOWER Study

US ophthalmic review, 2019, Vol.12 (2), p.88

2019

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Aktive Filter

PublikationsformBerichte

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(26)

Publikationsform

Sprache

Englisch
(41)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(30)
Science & Technology
(30)
Ophthalmology
(28)
Humans
(22)
Male
(18)
Female
(17)
Middle Aged
(17)
Double-Blind Method
(15)
Adult
(14)
Treatment Outcome
(13)
Aged
(12)
Ophthalmic Solutions
(9)
Young Adult
(9)
Adolescent
(8)
Conjunctivitis, Allergic - Drug Therapy
(7)
Diabetic Retinopathy
(7)
Drug Dosages
(7)
Prospective Studies
(7)
Biological And Medical Sciences
(6)
Conjunctivitis
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pilocarpine HCl 1.25% for treatment of presbyopia after laser vision correction: pooled analysis of two phase 3 randomized trials (GEMINI 1 and 2)

Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study

Omidenepag Isopropyl in Latanoprost Low/Nonresponders With Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 3, Nonrandomized, Two-Phase, Open-Label Study

Phase 3 Randomized Study of Efficacy and Safety of a Dexamethasone Intracanalicular Insert in Patients With Allergic Conjunctivitis

A Randomized, Multicenter Phase 3 Clinical Trial Evaluating Intracanalicular Dexamethasone Insert for the Treatment of Allergic Conjunctivitis

Efficacy and Safety of the Melanocortin Pan-Agonist PL9643 in a Phase 2 Study of Patients with Dry Eye Disease

A randomized, vehicle-controlled, Phase 2b study of two concentrations of the TRPM8 receptor agonist AR-15512 in the treatment of dry eye disease (COMET-1)

A Phase 2 Randomized, Double-Masked, Placebo-Controlled Study of a Novel Integrin Antagonist (SAR 1118) for the Treatment of Dry Eye

Plasma Pharmacokinetic Parameters of Dexamethasone Following Administration of a Dexamethasone Intracanalicular Insert in Healthy Adults

Ocular Itch Relief with Alcaftadine 0.25% Versus Olopatadine 0.2% in Allergic Conjunctivitis: Pooled Analysis of Two Multicenter Randomized Clinical Trials

Alcaftadine 0.25% Versus Olopatadine 0.2% In Prevention Of Ocular Itching In Allergic Conjunctivitis

Effect of alcaftadine 0.25% on ocular itch associated with seasonal or perennial allergic conjunctivitis: a pooled analysis of two multicenter randomized clinical trials

Lifitegrast Ophthalmic Solution 5.0% for Treatment of Dry Eye Disease

Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2)

Phase 3 Randomized Double-Masked Study of Efficacy and Safety of Once-Daily 0.77% Olopatadine Hydrochloride Ophthalmic Solution in Subjects With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge Model

Topical Anti-TNFα Agent Licaminlimab (OCS-02) Relieves Persistent Ocular Discomfort in Severe Dry Eye Disease: A Randomized Phase II Study

Topical Anti-TNF[alpha] Agent Licaminlimab Relieves Persistent Ocular Discomfort in Severe Dry Eye Disease: A Randomized Phase II Study

Topical Anti-TNF[alpha] Agent Licaminlimab

Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Three-Month Data from a Randomized Phase 3 Trial

A Water-free 0.1% Cyclosporine A Solution for Treatment of Dry Eye Disease: Results of the Randomized Phase 2B/3 ESSENCE Study

Brimonidine Ophthalmic Solution 0.025% for Reduction of Ocular Redness: A Randomized Clinical Trial

Repository Corticotropin Injection (Acthar® Gel) for Refractory Severe Noninfectious Keratitis: Efficacy and Safety from a Phase 4, Multicenter, Open-Label Study

Low-dose brimonidine for relief of ocular redness: integrated analysis of four clinical trials

Vehicle-Controlled, Phase 2 Clinical Trial of a Sustained-Release Dexamethasone Intracanalicular Insert in a Chronic Allergen Challenge Model

Efficacy and Safety of Topical Cyclosporine in Dry Eye Subjects Who Engage in Electronic Visual Tasking—The EMPOWER Study

Aktive Filter

Suchergebnisse filtern